Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ulcerative colitis
ulcerative colitis
Galapagos avoids 'complete whiff' as key anti-inflammatory drug fails to beat placebo in midphase trials
Fierce Biotech
Thu, 07/15/21 - 12:25 pm
Galapagos
clinical trials
rheumatoid arthritis
ulcerative colitis
psoriasis
filgotinib
Galapagos Touts Positive Post-Hoc Data, but Likely Won’t Gun for US Approval
BioSpace
Mon, 07/12/21 - 11:35 pm
Galapagos
ulcerative colitis
filgotinib
AbbVie says Rinvoq shines again as maintenance therapy for ulcerative colitis — but safety concerns still loom over JAK class
Endpoints
Wed, 06/30/21 - 10:49 am
AbbVie
ulcerative colitis
clinical trials
Rinvoq
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
clinical trials
Merck
Ridgeback Biotherapeutics
COVID-19
Intellia Therapeutics
transthyretin amyloidosis
Arcus Biosciences
Gilead Sciences
lung cancer
Sanofi
GSK
vaccines
uniQure
Huntington's disease
Mirati Therapeutics
gene editing
Seres Therapeutics
ulcerative colitis
Sarepta Therapeutics
Duchenne Muscular Dystrophy
How Big Is Bristol Myers Squibb's Latest FDA Approval?
Motley Fool
Sun, 06/13/21 - 10:42 pm
Bristol Myers Squibb
Zeposia
ulcerative colitis
FDA
BMS Flying High in May With Opdivo, Zeposia FDA Approvals
BioSpace
Fri, 05/28/21 - 11:23 am
Bristol Myers Squibb
FDA
clinical trials
Opdivo
Zeposia
ozanimod
ulcerative colitis
Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia
Fierce Biotech
Mon, 05/17/21 - 10:44 am
LianBio
Landos Biopharma
IPOs
ulcerative colitis
Crohn's Disease
China
Asia
I-Mab's IL-6 drug hits goal in ulcerative colitis phase 2
Fierce Biotech
Mon, 04/26/21 - 10:54 am
I-Mab Biopharma
ulcerative colitis
clinical trials
Lilly's Skyrizi rival hits goal in ulcerative colitis phase 3, as it ups the ante against AbbVie
Fierce Biotech
Tue, 03/16/21 - 10:56 am
Eli Lilly
clinical trials
mirikizumab
ulcerative colitis
Bristol Myers Squibb turns in priority review voucher for supplemental indication on an old Celgene drug
Endpoints
Wed, 02/3/21 - 10:55 am
Bristol-Myers Squibb
Celgene
FDA
ulcerative colitis
priority review
Zeposia
GSK suffers another R&D setback, axing ulcerative colitis drug trial
Pharmaforum
Mon, 01/25/21 - 10:58 am
GSK
ulcerative colitis
R&D
GSK2831781
GlaxoSmithKline's Immutep-partnered midstage GI med culled in ulcerative colitis
Fierce Biotech
Fri, 01/22/21 - 10:37 am
GSK
R&D
IMMUTEP
ulcerative colitis
AbbVie's Hopes of Replacing Humira Sales with Rinvoq Gains Momentum for Ulcerative Colitis
BioSpace
Wed, 12/9/20 - 11:21 pm
AbbVie
Rinvoq
ulcerative colitis
clinical trials
Gilead and Galapagos's filgotinib shows sustained efficacy in ulcerative colitis study
Seeking Alpha
Tue, 10/13/20 - 11:17 am
filgotinib
Gilead Sciences
Galapagos
clinical trials
ulcerative colitis
Bristol Myers Squibb's Zeposia boosts remission rates over placebo in ulcerative colitis patients
Fierce Pharma
Sun, 10/11/20 - 10:29 pm
Bristol-Myers Squibb
Zeposia
ulcerative colitis
clinical trials
Arena doses first subject in ELEVATE UC 12 phase 3 trial of Etrasimod in ulcerative colitis
Pharmaceutical Business Review
Mon, 09/28/20 - 10:52 am
Arena Pharmaceuticals
clinical trials
etrasimod
ulcerative colitis
Hits, but mostly misses for Roche’s 4 late-stage trials of GI drug hopeful etrolizumab
Fierce Biotech
Mon, 08/10/20 - 10:53 am
Roche
Genentech
etrolizumab
clinical trials
ulcerative colitis
BMS' Recently Approved MS Drug Shows Promise in Ulcerative Colitis Study
BioSpace
Tue, 06/2/20 - 11:20 pm
Bristol-Myers Squibb
Zeposia
ozanimod
ulcerative colitis
Galapagos finds little comfort in safety
EP Vantage
Fri, 05/22/20 - 10:28 am
Galapagos
filgotinib
ulcerative colitis
Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes
Fierce Biotech
Thu, 05/21/20 - 10:28 am
Gilead Sciences
Galapagos
filgotinib
ulcerative colitis
clinical trials
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »